CuraGen Corporation – ‘8-K’ for 10/24/02

On:  Thursday, 10/24/02, at 4:47pm ET   ·   For:  10/24/02   ·   Accession #:  927016-2-5032   ·   File #:  0-23223

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                         3      9K 
 2: EX-99.1     Press Release                                          4     20K 

8-K   —   Current Report
Document Table of Contents

8-K
1st Page of 3
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

--------------

FORM 8-K

CURRENT REPORT

 Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

--------------

Date of Report (Date of earliest event reported): October 24, 2002    

 CuraGen Corporation
(Exact name of registrant as specified in its charter)

Delaware                      0-23223                       06-1331400    
---------------                -----------                  ------------------  
(State or other                (Commission                  (IRS Employer       
jurisdiction of                File Number)                 Identification No.) 
incorporation)                                                                  

555 Long Wharf Drive, 11th Floor
New Haven, Connecticut 06511
------------------------------------------------------------------------------- 
 (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code: (203) 401-3330              

------------------------------------------------------------------------------- 

8-K
2nd Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 2nd
Item 5.   Other Events and Regulation FD Disclosure.                            

On October 24, 2002, the Registrant issued a press release announcing its       
financial results for the third quarter which ended September 30, 2002. A copy  
of the press release is attached to this Current Report on Form 8-K as Exhibit  
99.1.                                                                           

Item 7.   Financial Statements and Exhibits.                                    

(c)  The following exhibits are filed with this report:                         

Exhibit Number                      Description                                 

99.1                                Press Release dated October 24, 2002.       

8-K
Last Page of 3
TOC
1st
Previous
Next
↓Bottom
Just 3rd
SIGNATURES

  Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the        
undersigned hereunto duly authorized.                                           

                   CURAGEN CORPORATION
            (Registrant)

Date: October 24, 2002                  By: /s/ David M. Wurzer                 
                                          ------------------------------------
                      Name:  David M. Wurzer
                                   Title: Executive Vice President and
                                     Chief Financial Officer

Dates Referenced Herein   and   Documents Incorporated by Reference

				Referenced-On Page
This ‘8-K’ Filing		Date		First		Last			Other Filings
Filed on / For Period End:		10/24/02		1		3
		9/30/02		2					10-Q
									List all Filings